Showing 1,658 news articles about Hepatitis & HIV

Filters Content type: Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Pharmaceutical industry

Vertex ends hepatitis C investment as sales fall

Editor's pick
CNBC
2 May 2014
Hepatitis B

Hepatitis B a growing problem in UK prisons

Editor's pick
The Independent
1 May 2014
Elimination of hepatitis C

Eliminating Hepatitis C Within a Generation. What are you going to do about it?

Editor's pick
You Tube / Jon Derricott
30 April 2014
Pharmaceutical industry

Biotech’s Hard Bargain

Editor's pick
The New Yorker
24 April 2014
Hepatitis B

Anti-HBV antiretrovirals may help ward off HBV infection in MSM

Editor's pick
International AIDS Society
24 April 2014
Harm reduction

Reducing the Risk for HIV, Hepatitis C Among Injection Drug Users

Editor's pick
Infectious Disease Special Edition
24 April 2014
Hepatitis C transmission & prevention

Studies investigate presence of hepatitis C virus among gay and bisexual men

Editor's pick
CATIE
24 April 2014
New & experimental hepatitis C treatment

AbbVie Submits New Drug Application to U.S. FDA for its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C

Editor's pick
AbbVie press release
23 April 2014
Pharmaceutical industry

Gilead Beats Hepatitis C Sales Estimates by $1 Billion

Editor's pick
Bloomberg
23 April 2014
Access to healthcare

NHS England agrees funding for life-saving hepatitis C drug

Editor's pick
NHS England (press release)
17 April 2014
New & experimental hepatitis C treatment

England: Patients with end-stage liver disease caused by hepatitis C to get new drug

Editor's pick
The Guardian
17 April 2014
Epidemiology

Viral hepatitis more deadly than HIV in Europe

Editor's pick
Science Daily
14 April 2014
Activism & civil society

International Liver Conference: activists demand affordable hepatitis C treatment

Editor's pick
HepCoalition
11 April 2014
Pharmaceutical industry

U.S. drug industry group defends price of Gilead hepatitis drug

Editor's pick
Reuters
11 April 2014
New & experimental hepatitis C treatment

Egypt: New Treatments May Defuse Viral Hepatitis Time Bomb

Editor's pick
Inter Press Service
10 April 2014
Hepatitis C treatment

WHO joins clamour to make new hepatitis C pills affordable

Editor's pick
Reuters
9 April 2014
Hepatitis C treatment

WHO issues its first hepatitis C treatment guidelines

Editor's pick
World Health Organization
9 April 2014
Hepatitis C symptoms & diagnosis

WHO Hepatitis Treatment Guidelines: UNITAID Urges Efforts to Improve Diagnosis as Key to Increase Access to Medicines

Editor's pick
UNITAID
9 April 2014
Pharmaceutical industry

Gilead Sciences: How serious is the pricing problem?

Editor's pick
Barron's
9 April 2014
Access to healthcare

Gilead aims to license hepatitis C drug to 3-4 Indian firms

Editor's pick
Reuters
9 April 2014
Pharmaceutical industry

Express Scripts Raises Pressure on Gilead for Drug Price

Editor's pick
Bloomberg
8 April 2014
Hepatitis C transmission & prevention

First European Conference on Hepatitis C and Drug Use, Berlin, 23-24 October 2014

Editor's pick
EATG
7 April 2014
Hepatitis C treatment

Costs to public of $84,000 hep C drug ‘outrageous' - Kaiser Permanente

Editor's pick
Reuters
3 April 2014
Hepatitis C treatment

Push Comes To Shove: Gilead's $1,000 Pill Could Hurt Insurer Earnings

Editor's pick
Forbes
31 March 2014